Bills · HR 1806
IN COMMITTEE· 119TH CONGRESS
House BillHR 1806Health
Triple-Negative Breast Cancer Research and Education Act of 2025
INTRO MAR 3· LAST ACTION MAR 3
READING
5MIN
COSPONSORS
13
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because triple-negative breast cancer (TNBC) is a particularly aggressive and challenging form of breast cancer. Unlike other types, it lacks the specific receptors that allow for targeted hormone therapies, making treatment more difficult and often requiring more intensive chemotherapy. Currently, there are significant gaps in understanding TNBC, especially regarding its prevalence, treatment costs, prevention, and cure in minority women, who are disproportionately affected.
If this bill becomes law, it could lead to breakthroughs in research, potentially uncovering new prevention methods or more effective treatments for TNBC. Increased public awareness could empower more women to seek early screening and diagnosis, which is crucial for survival rates given the cancer's aggressive nature. For healthcare providers, better information means more informed care. Without this bill, research efforts might remain less coordinated, and public and professional awareness might not improve at the targeted rate needed to address this critical health disparity.
KEY PROVISIONS
4AI-extractedPROVISION 01
Directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research efforts specifically on triple-negative breast cancer.
This aims to close knowledge gaps about this aggressive cancer, potentially leading to new treatments or prevention strategies.
PROVISION 02
Requires the Centers for Disease Control and Prevention (CDC) to develop and spread public information about triple-negative breast cancer, including its elevated risk for minority women.
This educates the public, particularly at-risk groups, on early detection and treatment options.
PROVISION 03
Mandates the Health Resources and Services Administration (HRSA) to provide healthcare professionals with current information on triple-negative breast cancer, its risks, and treatment options.
This ensures doctors are up-to-date on best practices for diagnosing and treating this cancer, especially in minority women.
PROVISION 04
Authorizes unspecified funding (such sums as may be necessary) for these research and education activities for fiscal years 2026 through 2031.
This provides the necessary financial backing to implement the bill's goals over several years.
SPONSORSHIP
1 + 13
D· New York
YRS IN OFFICE
7
BILLS LED
37
COSPONSOR BREAKDOWNBIPARTISAN · 30%
DEM 11 REP 2 IND 0
ACTION TIMELINE
2 EVENTSMAR 3
Introduced in House
MAR 3
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 1806
Congress119th
StatusIn Committee
IntroducedMar 3, 2025
Last actionMar 3, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED MAR 3, 2025
House BillHR 1806Health
Triple-Negative Breast Cancer Research and Education Act of 2025
INTRODUCED MAR 3, 2025· LAST ACTION MAR 3, 2025
PASSAGE CHANCES
—%
READING
5 min
COSPONSORS
13
COMPLEXITY
Moderate
